Cholesterol and Lipoproteins Quiz
44 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary composition of LDLs?

  • Mainly composed of triglycerides (50%)
  • Mainly composed of phospholipids (50%)
  • Mainly composed of proteins (50%)
  • Mainly composed of cholesterol (50%) (correct)

    • What is the primary function of HDLs?

  • Transport triglycerides from the liver to the tissues
  • Remove excess cholesterol from the body and transport it to the liver (correct)
  • Transport cholesterol from the liver to the tissues
  • Hydrolyze triglycerides in chylomicrons

    • What is the primary source of cholesterol for the endogenous pathway of lipid transport?

  • Adipose tissue
  • Muscle tissue
  • Liver (correct)
  • Chylomicron remnants

    • What happens to VLDL as it releases triglycerides?

    <p>It becomes smaller and denser, transforming into LDL (B)</p> Signup and view all the answers

    What is the primary role of lipoprotein lipase in the exogenous pathway?

    <p>Hydrolyzing triglycerides in chylomicrons to release free fatty acids (A)</p> Signup and view all the answers

    What is the primary mechanism by which cells take up LDL?

    <p>Endocytosis via LDL receptors (C)</p> Signup and view all the answers

    What effect does the reduced inactive form of MLCK have on the body?

    <p>Increased bronchoconstriction (C)</p> Signup and view all the answers

    Why is LDL-cholesterol often referred to as "bad" cholesterol?

    <p>It can contribute to the formation of fatty plaques in arteries. (D)</p> Signup and view all the answers

    What is the primary role of HDL-cholesterol in preventing coronary artery disease?

    <p>It removes excess cholesterol from the body and transports it to the liver. (B)</p> Signup and view all the answers

    Which of the following is a beta-blocker that is contraindicated in slow metabolizers with asthma?

    <p>Propranolol (C)</p> Signup and view all the answers

    Which of the following events is NOT involved in the pathway leading to relaxation of smooth muscle?

    <p>Activation of Myosin Light Chain Kinase (B)</p> Signup and view all the answers

    Which of the following is a clinical use for beta-blockers?

    <p>Treatment of anxiety disorders (A)</p> Signup and view all the answers

    Which of the following is NOT a known adverse effect of beta-blockers?

    <p>Hypertension (C)</p> Signup and view all the answers

    Which of the following best describes the primary mechanism of action for PCSK9 inhibitors?

    <p>They prevent the degradation of LDL receptors, allowing for more efficient removal of LDL cholesterol from the bloodstream. (B)</p> Signup and view all the answers

    What are the primary adverse effects associated with statin therapy?

    <p>Liver and muscle problems (C)</p> Signup and view all the answers

    Which of the following is a contraindication for the use of PCSK9 inhibitors?

    <p>Patients with a history of hypersensitivity reactions to the drug (B)</p> Signup and view all the answers

    What is the primary mechanism of action for omega-3 acid ethyl esters in reducing triglyceride levels?

    <p>They directly inhibit the synthesis of triglycerides in the liver. (C)</p> Signup and view all the answers

    What is the primary mode of action for fibrates like gemfibrozil and fenofibrate?

    <p>Activation of lipoprotein lipase through interaction with PPAR-α (A)</p> Signup and view all the answers

    What is the primary clinical application of omega-3 acid ethyl esters in the treatment of lipid disorders?

    <p>Treatment of hypertriglyceridemia in combination with statins. (D)</p> Signup and view all the answers

    Which of the following is a common gastrointestinal adverse effect associated with the use of omega-3 acid ethyl esters?

    <p>Constipation. (C)</p> Signup and view all the answers

    In which scenario would PCSK9 inhibitors be a suitable option for treating hypercholesterolemia?

    <p>Patients who are unable to tolerate statins due to adverse effects (B)</p> Signup and view all the answers

    What is a common reason for the use of PCSK9 inhibitors in conjunction with statins?

    <p>To increase the efficacy of statin therapy by achieving greater LDL-C reduction (C)</p> Signup and view all the answers

    Which of the following is a contraindication for the use of omega-3 acid ethyl esters?

    <p>Allergy to fish. (A)</p> Signup and view all the answers

    What is a potential concern associated with the use of omega-3 acid ethyl esters in certain patients?

    <p>Increased risk of bleeding. (B)</p> Signup and view all the answers

    Which of the following is a common adverse effect associated with PCSK9 inhibitors?

    <p>Injection site reactions, such as redness, swelling, or pain (D)</p> Signup and view all the answers

    What is the recommended dosage for omega-3 acid ethyl esters?

    <p>2-4g or more per day. (B)</p> Signup and view all the answers

    The content mentions that HMG-CoA reductase is most active after a meal. What does this indicate about the body's cholesterol synthesis after eating?

    <p>Cholesterol synthesis is primarily driven by the body's own production after meals. (B)</p> Signup and view all the answers

    In which of the following conditions are omega-3 acid ethyl esters NOT indicated?

    <p>Hyperchylomicronemia. (C)</p> Signup and view all the answers

    Which of the following is a proposed mechanism of action for omega-3 acid ethyl esters that has not yet been fully confirmed?

    <p>Increased free fatty acid breakdown. (A)</p> Signup and view all the answers

    What is the primary mechanism by which beta-blockers decrease contractility in cardiac myocytes?

    <p>Reduction in cAMP levels through inhibition of adenylyl cyclase (A)</p> Signup and view all the answers

    Which of the following is NOT a direct consequence of beta-blocker activity in cardiac myocytes?

    <p>Increased calcium sensitivity of the contractile proteins (A)</p> Signup and view all the answers

    What is the primary mechanism by which beta-blockers contribute to bronchoconstriction?

    <p>Inhibition of β2-adrenergic receptors in bronchial smooth muscle cells (D)</p> Signup and view all the answers

    Which of the following accurately describes the relationship between beta-blockers and contractility in cardiac myocytes?

    <p>Beta-blockers decrease contractility by inhibiting adenylyl cyclase activity and reducing cAMP levels. (A)</p> Signup and view all the answers

    What is the primary role of cAMP in the regulation of smooth muscle contraction?

    <p>Reducing phosphorylation of myosin light chains, leading to relaxation. (A)</p> Signup and view all the answers

    Which of the following is true regarding the mechanism of beta-blocker-associated bronchoconstriction?

    <p>Beta-blockers inhibit β2-adrenergic receptors in bronchial smooth muscle cells, reducing cAMP levels. (B)</p> Signup and view all the answers

    Why are beta-blockers contraindicated in pregnancy?

    <p>They can cross the placenta and potentially harm the developing fetus. (C)</p> Signup and view all the answers

    What is the primary function of renin in the angiotensin conversion process?

    <p>To cleave angiotensinogen to form Angiotensin I (B)</p> Signup and view all the answers

    What adverse effect is commonly associated with Angiotensin Converting Enzyme Inhibitors (ACE-I)?

    <p>Dry cough (A)</p> Signup and view all the answers

    Which of the following statements is true about Angiotensin II?

    <p>It acts as a powerful vasoconstrictor (C)</p> Signup and view all the answers

    Which mechanism is primarily affected by an ACE-I?

    <p>Conversion of Angiotensin I to Angiotensin II (C)</p> Signup and view all the answers

    Which of the following is a contraindication for using ACE inhibitors?

    <p>Pregnancy (C)</p> Signup and view all the answers

    What is the effect of bradykinin accumulation during ACE-I therapy?

    <p>It reduces vascular resistance and increases blood flow (C)</p> Signup and view all the answers

    Which of the following drugs is an example of an Angiotensin II type 1 (AT1) blocker?

    <p>Losartan (B)</p> Signup and view all the answers

    What potential outcome can occur with the use of ACE inhibitors concerning renal function?

    <p>Acute renal failure (C)</p> Signup and view all the answers

    Flashcards

    Vasodilation pathway

    The process leads to blood vessel relaxation via nitric oxide and cGMP.

    MLCK

    Myosin light chain kinase; enzyme that plays a role in muscle contraction and relaxation.

    Non-selective beta-blockers

    Beta-blockers that affect both β1 and β2 receptors, e.g., Propranolol.

    Cardioselective beta-blockers

    Beta-blockers that mainly affect β1 receptors, minimizing lung effects, e.g., Metoprolol.

    Signup and view all the flashcards

    Adverse effects of beta-blockers

    Potential negative reactions including hypotension and bronchoconstriction, especially in asthmatics.

    Signup and view all the flashcards

    C-terminal

    The end of a peptide chain that contains a free carboxyl group.

    Signup and view all the flashcards

    Renin

    An enzyme that cleaves angiotensinogen to form Angiotensin I, activated by low blood pressure.

    Signup and view all the flashcards

    ACE (Angiotensin Converting Enzyme)

    An enzyme that converts Angiotensin I to the active Angiotensin II.

    Signup and view all the flashcards

    Angiotensin II

    The active form, a potent vasoconstrictor that raises blood pressure.

    Signup and view all the flashcards

    Angiotensin Converting Enzyme Inhibitors (ACE-I)

    Medications that inhibit ACE, reducing Angiotensin II levels, lowering blood pressure.

    Signup and view all the flashcards

    Bradykinin

    A substance that accumulates due to ACE-I, promoting vasodilation and increasing blood flow.

    Signup and view all the flashcards

    Adverse Effects of ACE-I

    Risks include severe hypotension, renal failure, hyperkalemia, angioedema, and dry cough.

    Signup and view all the flashcards

    AT1 blockers

    Medications like Valsartan that block Ang II from binding to its receptors, lowering blood pressure.

    Signup and view all the flashcards

    Intermediate-Density Lipoproteins (IDLs)

    IDLs form from the depletion of triglycerides in VLDL and can become LDL or be taken up by the liver.

    Signup and view all the flashcards

    Low-Density Lipoproteins (LDLs)

    LDLs are lipoproteins primarily made of cholesterol and are known as 'bad' cholesterol due to their role in plaque formation.

    Signup and view all the flashcards

    High-Density Lipoproteins (HDLs)

    HDLs are lipoproteins that transport cholesterol to the liver for elimination and are known as 'good' cholesterol.

    Signup and view all the flashcards

    Beta-Blockers

    Medications that inhibit beta-adrenoceptors, reducing heart rate and contractility.

    Signup and view all the flashcards

    Mechanism of Action (MOA)

    The process by which beta-blockers affect heart and bronchial smooth muscle function.

    Signup and view all the flashcards

    LDL composition

    LDLs consist of 50% cholesterol, 25% proteins, 20% phospholipids, and 5% triglycerides.

    Signup and view all the flashcards

    Chylomicrons

    Chylomicrons are lipoproteins that transport dietary triglycerides and cholesterol from the intestines to other tissues.

    Signup and view all the flashcards

    B1-blockade

    Inhibition of beta-1 receptors, leading to reduced contractility in cardiac muscles.

    Signup and view all the flashcards

    Exogenous Pathway

    The pathway that transports dietary cholesterol via chylomicrons to tissues and liver.

    Signup and view all the flashcards

    Calcium Induced Calcium Release (CICR)

    A mechanism where calcium influx triggers further calcium release from the sarcoplasmic reticulum.

    Signup and view all the flashcards

    Bronchoconstriction

    Narrowing of the airways caused by contraction of the bronchial muscles.

    Signup and view all the flashcards

    Endogenous Pathway

    The pathway where the liver produces VLDL transporting cholesterol to tissues, converting to LDL.

    Signup and view all the flashcards

    Lipoprotein uptake

    Cells uptake LDL by endocytosis through LDL receptors that recognize apolipoproteins.

    Signup and view all the flashcards

    B2-blockade

    Inhibition of beta-2 receptors, leading to decreased vasodilation and potential bronchoconstriction.

    Signup and view all the flashcards

    cAMP

    Cyclic adenosine monophosphate, a signaling molecule that promotes relaxation in muscles.

    Signup and view all the flashcards

    The effect of lipoprotein lipase

    Stimulates lipoprotein lipase activity, decreasing plasma triacylglycerol levels.

    Signup and view all the flashcards

    Clinical uses of Omega-3-acid ethyl esters

    Used for hypertriglyceridaemia and familial combined hyperlipidaemia.

    Signup and view all the flashcards

    Adverse effects of Omega-3

    Common effects include gastrointestinal issues, skin rashes, and myositis.

    Signup and view all the flashcards

    Decrease in VLDL levels

    Result of decreased secretion from the liver, along with lipoprotein lipase activity.

    Signup and view all the flashcards

    Role of EPA and DHA

    Poor substrates for diglyceride acyltransferase, reducing triglyceride biosynthesis.

    Signup and view all the flashcards

    Contraindications for fish oil

    Contraindicated for individuals allergic to fish and may increase bleeding times.

    Signup and view all the flashcards

    Increase in HDL levels

    Moderate rise in HDL occurs with certain lipid treatments.

    Signup and view all the flashcards

    Therapeutic combination for Type I

    Statins are recommended for pure type I and combination therapy for type I + triglycerides.

    Signup and view all the flashcards

    HMG-CoA Reductase Inhibitors

    Medications like Lovastatin and Simvastatin that lower cholesterol by inhibiting HMG-CoA reductase.

    Signup and view all the flashcards

    Adverse Effects of Statins

    Includes liver abnormalities, muscle issues like myopathy, and contraindications in pregnancy.

    Signup and view all the flashcards

    PCSK9 Inhibitors

    Drugs like Evolocumab that prevent LDL receptor degradation, increasing LDL uptake.

    Signup and view all the flashcards

    Clinical Uses of PCSK9 Inhibitors

    Used for lowering LDL in patients intolerant to statins and those needing further reduction.

    Signup and view all the flashcards

    Characteristics of PCSK9 Inhibitors

    Monoclonal antibodies requiring injection, with a half-life of 10-20 days.

    Signup and view all the flashcards

    Fibrates

    Medications like Gemfibrozil that activate PPAR-α to increase lipoprotein lipase activity.

    Signup and view all the flashcards

    PPAR-α Activation by Fibrates

    Fibrates act as ligands for PPAR-α, enhancing lipoprotein lipase activity.

    Signup and view all the flashcards

    Side Effects of PCSK9 Inhibitors

    Possible injection site reactions and increased incidence of nasopharyngitis.

    Signup and view all the flashcards

    Study Notes

    Lipid Lowering Medications

    • Hyperlipidemia and atherosclerosis: Coronary artery disease (CAD) is linked to plasma cholesterol and triacylglycerol levels in lipoprotein particles.

    • Lipids and lipoproteins: Lipids (hydrophobic) are transported as lipoproteins. Lipoproteins consist of nonpolar lipids (cholesterol esters, triglycerides) and amphipathic lipids (phospholipids, cholesterol). Lipoproteins of different densities are distinguished by their triglyceride and protein contents.

    • Separation of lipoproteins: Triglyceride content inversely correlates with lipoprotein density. Higher protein content results in higher density. Lipoproteins are separated by ultracentrifugation, ranging from chylomicrons (lowest density) to HDL (highest density).

    • Chylomicrons: Formed in small intestine mucosal cells, these contain dietary lipids for adipose tissue storage. Primarily composed of triglycerides (85%).

    • Very low-density lipoproteins (VLDLs): Synthesized in hepatocytes, primarily carrying endogenous lipids. Contain triglycerides (50%).

    • Intermediate-density lipoproteins (IDLs): Derived from VLDL triglyceride depletion, taken up by the liver for reprocessing or further triglyceride depletion, becoming LDL. Contains a mix of triglycerides (24-30%) and cholesterol (32-37%).

    • Low-density lipoproteins (LDLs): Deposit cholesterol in arteries, increasing coronary artery disease risk. Cholesterol content is high (50%). Known as "bad" cholesterol.

    • High-density lipoproteins (HDLs): Removing excess cholesterol from body cells and transporting it to the liver for elimination. High HDL levels are associated with reduced coronary artery disease risk. High protein content results in high density.

    • Cholesterol transport in tissues (exogenous pathway): -Chylomicrons carry dietary lipids. -Lipoprotein lipase hydrolyzes triglycerides into fatty acids, absorbed by tissues. -Remnants of chylomicrons are taken up by the liver by endocytosis.

    • Cholesterol transport in tissues (endogenous pathway): -VLDL transports lipids from the liver. -Triglycerides are hydrolyzed, lipoproteins transform to LDLs. -LDL receptors take up LDLs in cells. -Cholesterol is returned to circulating blood in HDLs.

    Classification of Hyperlipoproteinaemias

    • Types of hyperlipoproteinemia: Different types (I-V) are classified by the specific lipoprotein elevations, and the associated cause. (Table included in the original document)

    Treatment Strategies for Dyslipidaemias

    • Diet and Lifestyle: Lifestyle changes (diet, exercise) can help improve lipid profiles.

    • Drugs:

      • HMG-CoA reductase inhibitors: Statins (atorvastatin, simvastatin, pravastatin, fluvastatin) compete with HMG-CoA reductase, reducing cholesterol synthesis.
      • PCSK9 inhibitors: Evolocumab, Alirocumab, inhibit PCSK9 to enhance LDL receptors increasing LDL uptake and disposal.
      • Fibrates: Gemfibrozil, Fenofibrate, increase lipoprotein lipase activity, decreasing plasma triglycerides and increasing HDL levels.
      • Bile acid binding resins: Cholestyramine, bind bile acids, enhancing cholesterol conversion to bile acids, decreasing cholesterol.
      • Ezetimibe: Inhibits intestinal sterol absorption, preventing cholesterol absorption

    HMG-CoA Reductase Inhibitors (Statins)

    • Mechanism of action: Inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, decreasing cholesterol production. Also increases LDL receptors to clear LDL from blood.

    • Clinical uses: Effective in reducing LDL-C levels across various hyperlipidemia types and preventing cardiac events and mortality in ischemic heart disease.

    • Pharmacokinetics: Oral first-pass extraction, are effective primarily in the evening due to their peak effect after the evening meal.

    • Adverse effects: Liver dysfunction, myopathy (muscle pain), rare cases of rhabdomyolysis (severe muscle breakdown).

    PCSK9 Inhibitors

    • Mechanism of Action: Inhibit PCSK9, a protein that degrades LDL receptors, enhancing LDL receptor number at the cell surface for effective LDL uptake.

    • Clinical uses: Reduce LDL-C levels significantly, especially in familial hypercholesterolemia and when statins are not adequately tolerated or effective in lowering LDL.

    Fibrates

    • Mechanism of action: Activating PPAR-α, increases lipoprotein lipase activity, potentially lowering triglycerides and increasing HDL levels.

    • Clinical uses: Primarily used for hypertriglyceridemia, and for dysbetalipoproteinemia.

    • Adverse effects: Gastrointestinal issues (nausea), skin rashes, gallstones, myositis (muscle related issues).

    Omega-3 Acid Ethyl Esters

    • Mechanism of action: Reduces hepatic triglyceride production, increases TG clearance from VLDL, increasing free fatty acid breakdown (beta oxidation) and lipoprotein lipase activity.

    • Clinical uses: Used in hypertriglyceridemia (Type IV).

    • Adverse effects: Gastrointestinal disturbances (diarrhoea, flatulence, nausea), rarely allergic reactions.

    Bile Acid Binding Resins

    • Mechanism of action: Bind bile acids in the intestine, reducing bile acid reabsorption, stimulating cholesterol conversion into bile acids thereby raising cholesterol excretion into the bile.

    • Clinical Uses: Primarily used in hypercholesterolemia (type IIA).

    • Adverse effects: Gastrointestinal issues (constipation, nausea, flatulence). Impairs absorption of fat-soluble vitamins (Vitamin A, D, E, and K).

    Inhibitors of Intestinal Sterol Absorption (Ezetimibe)

    • Mechanism of action: Inhibiting the intestinal sterol transporter Niemann-Pick C1-Like-1 (NPC1L1) which lowers cholesterol absorption in the gut.

    • Clinical uses: Lowering LDL-C levels; a common combination drug is used in hyperlipidemia.

    • Adverse effects: Gastrointestinal side effects (diarrhea, flatulence). Rarer cases of rhabdomyolysis (muscle related issues) are also seen.

    Antihypertensive Medications

    • (This section contains information specific to antihypertensive medications and is too extensive for this format. Please specify which aspect you need study notes for, for example, drug classification, mechanism of action, adverse effects, clinical uses.)
    • General Note:* Some details and specific mechanisms of action are simplified for this summary. You are advised to review the original presentation for more detail.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Lipid Lowering Medications PDF

    Description

    Test your knowledge on the functions and roles of LDL and HDL cholesterols in lipid transport and cardiovascular health. This quiz also covers the mechanisms of beta-blockers and PCSK9 inhibitors in clinical practice. Challenge yourself to understand the complexities of lipoprotein metabolism!

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser